comparemela.com

Latest Breaking News On - Stephanie navarro silvera - Page 1 : comparemela.com

Moderna s dual COVID-flu vaccine moves to late-stage trial after signs of success

Moderna plans to begin a late-stage trial later this year of its combination vaccines that offer protection against both COVID-19 and the flu. Dr. Stephanie Navarro Silvera, a professor in the Department of Public Health at Montclair State University, explains why a dual shot would be considered “a win in terms of public health.” Source

New COVID treatments on horizon; could ease burden on hospitals

One pharmaceutical has asked the U.S. government to authorize its antiviral drug while another drugmaker's antibody cocktail shows promise in treating infected patients.

These medical experts helped N J navigate the pandemic Here s how they re spending their summer vacations

These medical experts helped N.J. navigate the pandemic. Here’s how they’re spending their summer vacations. Updated Apr 28, 2021; Facebook Share Now the vaccination effort is fully underway and the CDC has loosened mask guidance, we’re all hoping for a more normal summer. And with the warm weather coming, people are making plans to see faraway family members, to visit their favorite vacation spots and take some time off. So what are the medical experts around the state planning to do? Most say they’re planning to stay close to home, though they said they would be willing to fly or stay in a hotel. Here’s how they are spending their summer vacations.

Top health official says N J will hit vaccination goal I can guarantee it

Should I take the J&J COVID vaccine if it becomes available? Experts say yes Here s why

Should I take the J&J COVID vaccine if it becomes available? Experts say yes. Here’s why. Updated Jan 30, 2021; Posted Jan 29, 2021 A scientist works in Janssen laboratory in Leiden, The Netherlands. Johnson & Johnson said Friday that its single-shot vaccine appears 66% effective overall at preventing moderate to severe COVID-19. It is more protective against severe symptoms, 85%. (Johnson & Johnson via AP)AP Facebook Share New data released Friday suggests Johnson & Johnson’s much-awaited coronavirus vaccine is less effective than the two vaccines already in use, but epidemiologists and scientists say it will still be a powerful force to overcome the virus.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.